Pediatric population (aged 3-11 years) received primary inactivated SARS-CoV-2 vaccination prior to infection exhibiting robust humoral immune response following infected with Omicron variant: a study conducted in Beijing.
Front Immunol
; 14: 1269665, 2023.
Article
en En
| MEDLINE
| ID: mdl-37828994
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Antígenos de Grupos Sanguíneos
/
COVID-19
País/Región como asunto:
Asia
Idioma:
En
Revista:
Front Immunol
Año:
2023
Tipo del documento:
Article